To determine whether antioxidants can influence human susceptibility to ozo
ne (O-3)-induced changes in lung function and airway inflammation, we place
d 31 healthy nonsmoking adults (18 to 35 yr old) on a diet low in ascorbate
for 3 wk. At 1 wk, subjects were exposed to filtered air for 2 h while exe
rcising (20 L/min/m(2)), and then underwent bronchoalveolar lavage (BAL) an
d were randomly assigned to receive either a placebo or 250 mg of vitamin C
, 50 IU of alpha -tocopherol, and 12 oz of vegetable cocktail daily for 2 w
k. Subjects were then exposed to 0.4 PPM O-3 for 2 h and underwent a second
BAL. On the day of the O-3 exposure, supplemented subjects were found to h
ave significantly increased levels of plasma ascorbate, tocopherols, and ca
rotenoids as compared with those of the placebo group. Pulmonary function t
esting showed that O-3-induced reductions in FEV1 and FVC were 30% and 24%
smaller, respectively, in the supplemented cohort. In contrast, the inflamm
atory response to O-3 inhalation, as represented by the percent neutrophils
and the concentration of interleukin-6 recovered in the BAL fluid at 1 h a
fter O-3 exposure was not different for the two groups. These data suggest
that dietary antioxidants protect against O-3-induced pulmonary function de
crements in humans.